Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats (original) (raw)
Renoprotective activity of aliskiren, a renin inhibitor in cyclosporine A induced hypertensive nephropathy in dTG mice
MEGHA SARASWAT
Pharmacological Reports, 2014
View PDFchevron_right
Aliskiren Normalizes Systolic Blood Pressure , Albuminuria , Glomerular Filtration Rate , and Cardiac Hypertrophy in RenTg Mice
Christos Chatziantoniou
View PDFchevron_right
Aliskiren Reduces Blood Pressure and Suppresses Plasma Renin Activity in Combination With a Thiazide Diuretic, an Angiotensin-Converting Enzyme Inhibitor, or an Angiotensin Receptor Blocker
Eoin O'Brien
View PDFchevron_right
Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases
Abul Najmi
Journal of Pharmacy and Pharmacology, 2012
View PDFchevron_right
Direct Renin inhibitor: aliskiren in chronic kidney disease
Yoshiyuki Morishita
Nephro-urology monthly, 2013
View PDFchevron_right
Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression
Maxime Pellegrin
Hypertension, 2008
View PDFchevron_right
Aliskiren for Renin Inhibition: A New Class of Antihypertensives
Mark Munger
Annals of Pharmacotherapy, 2007
View PDFchevron_right
Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats
Sonia Gandhi
Journal of the Renin-Angiotensin-Aldosterone System, 2012
View PDFchevron_right
Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans
William Dole
Circulation, 2008
View PDFchevron_right
Renoprotective Effects of Combined Aliskiren and Valsartan in Progressive Diabetic Nephropathy in Rats
Dr.Krishna Mohan Chinnala
International Journal of Pharmaceutical Sciences and Nanotechnology, 2011
View PDFchevron_right
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes
Frederik Persson
Kidney International, 2008
View PDFchevron_right
Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension
Timothy Doulton
Journal of Renin-Angiotensin-Aldosterone System, 2009
View PDFchevron_right
Direct inhibition of plasmatic renin activity with aliskiren: a promising but under-investigated therapeutic option for non-diabetic glomerulonephritis
Ramona Nicotera
International Urology and Nephrology, 2015
View PDFchevron_right
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction
Giovanni Mazzotta
Vascular health and risk management, 2008
View PDFchevron_right
Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension
Fulvio Bellocci
Advances in Therapy, 2009
View PDFchevron_right
Renin inhibitors in diabetes and hypertension: an update
Yagiz Uresin
EXCLI Journal, 2014
View PDFchevron_right
Aliskiren in the treatment of renal disease; a narrative review
Bijan Roshan
Journal of Parathyroid Disease, 2022
View PDFchevron_right
Renin Inhibition Reverses Renal Disease in Transgenic Mice by Shifting the Balance Between Profibrotic and Antifibrotic Agents
AHmed ABed
Hypertension, 2013
View PDFchevron_right
Aliskiren, the future of renin–angiotensin system blockade?
Yagiz Uresin
Expert Review of Cardiovascular Therapy, 2007
View PDFchevron_right
Safety of enhanced renin–angiotensin–aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease
Przemysław Rutkowski
Polish Archives of Internal Medicine, 2013
View PDFchevron_right
Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
Mehmed A Kulic, Vjekoslav Gerc, Marko Buksa
Medicinski arhiv, 2009
View PDFchevron_right
Protective effects of aliskiren and valsartan in mice with diabetic nephropathy
Jeffrey Kopp
Journal of the renin-angiotensin-aldosterone system : JRAAS, 2014
View PDFchevron_right
Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury—beyond the direct renin inhibition
Mai-szu Wu
Hypertension Research, 2012
View PDFchevron_right
Renoprotective effect of aliskiren monotherapy and aliskiren−pentoxifylline combination in hypertensive-diabetic type 2 patients with diabetic nephropathy
Mohammed Taha
Bulletin of Faculty of Pharmacy, Cairo University, 2013
View PDFchevron_right
Aliskiren Reduces the Adrenal Zona Glomerulosa Apoptosis and Autophagy in Wistar Rats with 2K1C Hypertension
Jemima Silva
International Journal of Hypertension
View PDFchevron_right
Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy
Dong Huang
Frontiers in physiology, 2017
View PDFchevron_right
Aliskiren: the first direct renin inhibitor available for clinical use
Alberto Morganti
Journal of Nephrology, 2011
View PDFchevron_right
Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Circulation 2008
William Dole
2015
View PDFchevron_right
Hypertension Management and End Organ Protection: Focus on Aliskiren
Takashi Akasaka
Clinical Medicine. Therapeutics
View PDFchevron_right
Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats
Nahed Hassanein
Naunyn-Schmiedeberg's Archives of Pharmacology, 2016
View PDFchevron_right
Optimal renin-angiotensin-aldosterone system control—direct renin inhibitors beyond blood pressure reductions
Sujatha Shetty
Journal of Indian College of Cardiology, 2011
View PDFchevron_right
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Hans-henrik Parving
New England Journal of Medicine, 2008
View PDFchevron_right
Renoprotection with antihypertensive effect by inhibition of rennin - angiotensin system
World Journal of Pharmaceutical Sciences
View PDFchevron_right